汉森制药：公司将通过提升盈利能力维护投资者信心

Group 1 - The company has established a shareholder return plan for the next three years (2024-2026), emphasizing cash dividends as the primary principle [2] - The company aims to enhance its profitability to maintain investor confidence while focusing on its core business [2]